Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease
- PMID: 9447502
- DOI: 10.1176/jnp.9.4.591
Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease
Abstract
This pilot study compared haloperidol, fluoxetine, and placebo for reduction of agitation in 15 outpatients with AD. The two drugs were no more effective than placebo at reducing agitation in these subjects; however, both drugs produced more toxicity than did placebo.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
